Weigert et al. (25) reported that Chemerin levels in the serum of patients with inflammatory bowel disease are elevated relative to those in the serum of healthy controls, indicating that Chemerin has a potential regulatory function in intestinal inflammation. This evidence concerns the gene RARRES2 and inflammatory bowel disease.